High baseline fibrinogen concentration as a risk factor of no tissue reperfusion in ST-segment elevation acute myocardial infarction treated with successful primary percutaneous coronary intervention

Kardiologia Polska

Volumn 64, Issue 9, 2006, Pages 967-972

  Wasilewski, Jarosław ^a,b   Osadnik, Tadeusz ^a   Poloński, Lech ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

^b III Kat i Oddzial Klin Kardiologii   (Poland)

Author keywords

Acute myocardial infarction; Fibrinogen; No reflow phenomenon; Primary PCI

Indexed keywords

CREATINE KINASE; FIBRINOGEN;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; FIBRINOGEN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; REPERFUSION INJURY; RISK FACTOR; ST SEGMENT ELEVATION; THORAX PAIN;

EID: 33750069450     PISSN: 00229032     EISSN: 00229032     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Wasilewski J, Turczyński B, Kowalik V, et al. Evaluation of hemorheological profiles in patients with no-reperfusion phenomenon in acute ST elevation myocardial infarction treated by primary percutaneous coronary intervention. J Vasc Biol 2005; 42 (Suppl. 2): 49.
2. Soutani M, Suzuki Y, Tateishi N, et al. Quantitative evaluation of flow dynamics of erythrocytes in microvessels: influence of erythrocyte aggregation. Am J Physiol 1995; 268: H1959-65.
3. Vicaut E. Opposite effects of red blood cell aggregation on resistance to blood flow. J Cardiovasc Surg (Torino) 1995; 36: 361-8.
4. Gu YJ, Graaff R, de Hoog E, et al. Influence of hemodilution of plasma proteins on erythrocyte aggregability: an in vivo study in patients undergoing cardiopulmonary bypass. Clin Hemorheol Microcirc 2005; 33: 95-107.
5. Assayag EB, Bornstein N, Shapira I, et al. Inflammation-sensitive proteins and erythrocyte aggregation in atherothrombosis. Int J Cardiol 2005; 98: 271-6.
6. Ercan M, Konukoglu D, Onen S. Plasma viscosity as a cardiovascular risk marker in patients with proteinuria. Clin Hemorheol Microcirc 2003; 29: 111-6.
7. Marton Z, Kesmarky G, Vekasi J, et al. Red blood cell aggregation measurements in whole blood and in fibrinogen solutions by different methods. Clin Hemorheol Microcirc 2001; 24: 75-83.
8. Ami RB, Barshtein G, Zeltser D, et al. Parameters of red blood cell aggregation as correlates of the inflammatory state. Am J Physiol Heart Circ Physiol 2001; 280: H1982-8.
9. Vaya A, Falco C, Reganon E, et al. Influence of plasma and erythrocyte factors on red blood cell aggregation in survivors of acute myocardial infarction. Thromb Haemost 2004; 91: 354-9.
10. Chien S, Jan K. Ultrastructural basis of the mechanism of rouleaux formation. Microvasc Res 1973; 5: 155-66.
11. Wong CK, French JK, Krucoff MW, et al. Slowed ST segment recovery despite early infarct artery patency in patients with Q waves at presentation with a first acute myocardial infarction. Implications of initial Q waves on myocyte reperfusion. Eur Heart J 2002; 23: 1449-55.
12. Palareti G, Maccaferri M, Manotti C, et al. Fibrinogen assays: a collaborative study of six different methods. C.I.S.M.E.L. Comitato Italiano per la Standardizzazione dei Metodi in Ematologia e Laboratorio. Clin Chem 1991; 37: 714-9.
13. Ishihara M, Inoue I, Kawagoe T, et al. Impact of prodromal angina pectoris and white blood cell count on outcome of patients with acute myocardial infarction. Int J Cardiol 2005; 103: 150-5.
14. Kosuge M, Kimura K, Ishikawa T, et al. Relation between white blood cell counts and myocardial reperfusion in patients with recanalized anterior acute myocardial infarction. Circ J 2004; 68: 526-31.
15. Iwakura K, Ito H, Kawano S, et al. Predictive factors for development of the no-reflow phenomenon in patients with reperfused anterior wall acute myocardial infarction. J Am Coll Cardiol 2001; 38: 472-7.
16. Feldman LJ, Coste P, Furber A, et al. Incomplete resolution of ST-segment elevation is a marker of transient microcirculatory dysfunction after stenting for acute myocardial infarction. Circulation 2003; 107: 2684-9.
17. Sanchis J, Bodi V, Navarro A, et al. Prognostic factors in unstable angina with dynamic electrocardiographic changes. Value of fibrinogen. Rev Esp Cardiol 2002; 55: 921-7.
18. Coppola G, Rizzo M, Abrignani MG, et al. Fibrinogen as a predictor of mortality after acute myocardial infarction: a forty-two-month follow-up study. Ital Heart J 2005; 6: 315-22.
19. Retterstol L, Kierulf P, Pedersen JC, et al. Plasma fibrinogen level and long-term prognosis in Norwegian middle-aged patients with previous myocardial infarction. A 10 year follow-up study. J Intern Med 2001; 249: 511-8.
20. Thompson SG, Fechtrup C, Squire E, et al. Antithrombin III and fibrinogen as predictors of cardiac events in patients with angina pectoris. Arterioscler Thromb Vasc Biol 1996; 16: 357-62.
21. De Sutter J, De Buyzere M, Gheeraert P, et al. Fibrinogen and C-reactive protein on admission as markers of final infarct size after primary angioplasty for acute myocardial infarction. Atherosclerosis 2001; 157: 189-96.
22. Yip HK, Chen MC, Chang HW, et al. Angiographic morphologic features of infarct-related arteries and timely reperfusion in acute myocardial infarction: predictors of slow-flow and no-reflow phenomenon. Chest 2002; 122: 1322-32.
23. Fu Y, Goodman S, Chang WC, et al. Time to treatment influences the impact of ST-segment resolution on one-year prognosis: insights from the assessment of the safety and efficacy of a new thrombolytic (ASSENT-2) trial. Circulation 2001; 104: 2653-9.
24. Snabre P, Bitbol M, Mills P. Cell disaggregation behavior in shear flow. Biophys J 1987; 51: 795-807.
25. Shiga T, Maeda N, Kon K. Erythrocyte rheology. Crit Rev Oncol Hematol 1990; 10: 9-48.
26. Camilleri JP, Joseph D, Fabiani JN, et al. Microcirculatory changes following early reperfusion in experimental myocardial infarction. Virchows Arch A Pathol Anat Histol 1976; 369: 315-33.
27. Tucker WY, Bean J, Vandevanter S, et al. The effect of hemodilution on experimental myocardial infarct size. Eur Surg Res 1980; 12: 1-11.